Volume Alert - AAPL 113.07 Apple Inc $AAPL Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - AAPL 113.07 Apple Inc $AAPL Hit a high today of 112.97 Closing the day 10:30 at 113.07 +1.82 +1.64% With a day low of 111.60 and a total volume of 14,743,938.

AAPL Recent Posts: http://investorshangout.com/Apple-Inc-AAPL-53191/

AAPL Apple Inc Recent Headline News

Qualcomm's Apple Problem
Mark Hibben - at Seeking Alpha - 1 hr 19 mins ago

QCOM: 70.63 (+0.34), INTC: 33.82 (+0.44), AAPL: 113.08 (+1.83), NVDA: 19.57 (-0.08)

Apple (AAPL) Stock Is Gaining Today on Higher Price Target
at The Street - 1 hr 21 mins ago
Apple (AAPL) stock is higher this morning after the iPhone maker had its price target raised to $120 from $110 at Bernstein.
AAPL: 113.08 (+1.83)

Google Nexus 6: How It Stacks Up Against the iPhone 6 Plus and the Competition
at The Street - 1 hr 28 mins ago
A terrific 'phablet' but it faces some very stiff competition for shoppers' hearts, minds and especially dollars.
QCOM: 70.63 (+0.34), SNE: 20.47 (-0.16), GOOG: 548.11 (+0.80), AAPL: 113.08 (+1.83)

Where Will Apple Stock Be In 10 Years?
Leo Sun, The Motley Fool - Motley Fool - 2 hrs 3 mins ago
Over the past ten years, Apple stock has soared nearly 1,300% thanks to robust demand for the iPhone and iPad, which together accounted for 71% of the company's top line last quarter. Between fiscal 2004 and 2014, Apple's annual revenue soared...
GOOGL: 559.13 (+0.88), MSFT: 49.25 (+0.47), GOOG: 548.11 (+0.80), AAPL: 113.08 (+1.83)

58.com (WUBA) in Focus: Stock Adds 11.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 14 mins ago
58.com Inc. (WUBA) was a big mover last session, as the company saw its shares rise more than 11% on the day.
WUBA: 45.75 (-0.37), AAPL: 113.08 (+1.83), ADBE: 71.86 (+0.45), ADSK: 59.48 (+0.50)

Where Apple Stock Will Be In 10 Years?
Leo Sun, The Motley Fool - Motley Fool - 2 hrs 21 mins ago
Over the past ten years, Apple stock has soared nearly 1,300% thanks to robust demand for the iPhone and iPad, which together accounted for 71% of the company's top line last quarter. Between fiscal 2004 and 2014, Apple's annual revenue soared...
GOOGL: 559.13 (+0.88), MSFT: 49.25 (+0.47), GOOG: 548.11 (+0.80), AAPL: 113.09 (+1.84)

Cramer's Mad Money - The Container Store Looks Forward To The Holidays (11/12/14)
SA Editor Miriam Metzinger - Seeking Alpha - 2 hrs 39 mins ago
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday November 12. CEO Interview: Kip Tindell, The Container Store (NYSE: TCS ) The Container Store ( TCS ) doubled after its IPO last year, but has fallen...
YHOO: 50.75 (+0.15), SAVE: 78.90 (+0.54), PNRA: 171.91 (+2.08), FB: 74.77 (+0.05), CMG: 669.72 (+5.47), AAL: 44.02 (+0.59), TCS: 22.70 (+0.05), DOW: 50.69 (+0.79), AAPL: 113.09 (+1.84), BABA: 118.67 (+0.47)

Jim Cramer's Top Stock Picks: AAPL DOW PNRA TCS
at The Street - Thu Nov 13, 5:00AM CST
Cramer reiterated that Apple stock should just be owned and not traded on the headlines.
PNRA: 171.91 (+2.08), CMG: 669.72 (+5.47), TCS: 22.70 (+0.05), DOW: 50.69 (+0.79), AAPL: 113.09 (+1.84)

‘Fast Money’ Recap: Now’s the Time for Investors to Buy Twitter
at The Street - Thu Nov 13, 4:00AM CST
The trading panel concluded that Twitter is a buy so long as management can increase user monetization. They also examined Macy's, J.C. Penney and Cisco after earnings.
FEYE: 33.58 (+0.43), IBM: 162.56 (+0.64), FB: 74.77 (+0.05), YCS: 83.84 (+0.19), JCP: 6.98 (-0.78), M: 60.92 (-0.65), BBY: 35.29 (+0.09), RNF: 13.19 (+0.91), TWTR: 42.98 (+0.44), AAPL: 113.11 (+1.86), CSCO: 25.60 (+0.49)

Apple: Up, Up And Away
Bill Maurer - at Seeking Alpha - Wed Nov 12, 11:13PM CST

AAPL: 113.10 (+1.85)

Xiaomi Escalating The Great Ecosystem Battle
WestEnd511 - at Seeking Alpha - Wed Nov 12, 11:00PM CST

BIDU: 247.58 (-2.24), GOOGL: 559.13 (+0.88), YOKU: 21.22 (-0.61), GOOG: 548.11 (+0.80), AAPL: 113.10 (+1.85)

Why The Tech Sector Is Leading U.S. Equities Higher
Andrew Sachais - at Seeking Alpha - Wed Nov 12, 10:59PM CST

YHOO: 50.75 (+0.15), SPY: 204.71 (+0.75), QQQ: 103.19 (+0.73), AAPL: 113.11 (+1.86), SIRI: 3.50 (+0.01)


YouTube adds subscription service to music mix
By MICHAEL LIEDTKE - AP - Wed Nov 12, 6:18PM CST
SAN FRANCISCO (AP) — Google is remixing the music on its YouTube video site with the addition of ad-free subscription service "Music Key" and a new format designed to make it easier to find millions of songs that can still be played for free.
1 Comment
GOOGL: 559.13 (+0.88), AAPL: 113.10 (+1.85), GOOG: 548.11 (+0.80)

Apple gains as prices hit lows
at Investor's Business Daily - Wed Nov 12, 5:51PM CST
While the smartphone maker's stock is busting ceilings, Apple's (AAPL) products are also poised to bust some doors this holiday shopping season. Shares rose 1.4% to hit an all-time high of 111.25. The stock action comes as Best Buy (BBY) and other...
BBY: 35.29 (+0.09), AAPL: 113.11 (+1.86)

BlackBerry Eyes Emerging Markets for Growth, BES10 Strong - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 5:36PM CST
On Nov 11, 2014, we issued an updated research report on BlackBerry Limited (BBRY).
BBRY: 11.57 (+0.30), AAPL: 113.11 (+1.86), GOOG: 548.11 (+0.80), SKM: 27.84 (-0.31)

Why Google Underperformed In 2014
Alex Cho - at Seeking Alpha - Wed Nov 12, 5:26PM CST

YHOO: 50.75 (+0.15), FB: 74.77 (+0.05), GOOGL: 559.13 (+0.88), MSFT: 49.25 (+0.47), GOOG: 548.11 (+0.80), AAPL: 113.12 (+1.87)

Why AT&T's Acquisition of Iusacell Could Be Great for Shareholders
Brian Nichols, The Motley Fool - Motley Fool - Wed Nov 12, 5:24PM CST
Last Friday AT&T announced a $2.5 billion cash deal to acquire Mexican wireless provider Iusacell. While Iusacell's customer base of 8.6 million might seem small, and rather insignificant to AT&T's business, this might just be an...
NFLX: 382.20 (-1.66), T: 35.81 (+0.41), AMX: 23.00 (+0.15), GOOGL: 559.13 (+0.88), VZ: 51.11 (+0.29), GOOG: 548.11 (+0.80), AAPL: 113.11 (+1.86)

Most active Nasdaq-traded stocks
AP - Wed Nov 12, 5:02PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
FB: 74.77 (+0.05), CMCSK: 54.22 (+0.82), ZNGA: 2.84 (+0.03), INTC: 33.82 (+0.44), GRPN: 7.92 (-0.18), SUSQ: 13.08 (-0.04), CMCSA: 54.42 (+0.82), AAPL: 113.11 (+1.86), CSCO: 25.61 (+0.50)

Final Glance: Computer companies
AP - Wed Nov 12, 5:02PM CST
NEW YORK (AP) — Shares of some top computer companies were mixed at the close of trading:
IBM: 162.56 (+0.64), AAPL: 113.11 (+1.86), LXK: 42.82 (+0.09)

Can Voxeljet (VJET) Surprise Earnings This Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 4:57PM CST
Voxeljet AG (VJET) is set to report third-quarter 2014 results on Nov 13. Last quarter, the company posted a positive surprise of 23.1%.
AUO: 4.57 (-0.11), IPXL: 29.48 (+0.09), VJET: 12.23 (+0.23), AAPL: 113.12 (+1.87)

Apple Inc. (AAPL) Stock Research Links

AAPL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 70

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 273

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 98

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 81

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 118

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 106

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 156

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 184

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Fluor Corporation's Recent Class Action Developments

Updated Category News Views 255

Fluor Corporation: An Overview of Recent Developments Fluor Corporation is a global leader in providing engineering, procurement, and construction (EPC) services, along with project management support. The company is dedicated to delivering essential infrastructure and the latest technology solutions while enhancing its operational efficiencies. Class Period and...

Continue Reading
Securing Your Rights: A Call to Sarepta Therapeutics Investors

Updated Category News Views 150

Urgent Reminder for Sarepta Therapeutics Investors In light of recent legal developments, it's crucial for investors of Sarepta Therapeutics, Inc. to take action regarding their investments in this biopharmaceutical company. Investors who acquired securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) are being notified of upcoming legal deadlines that could impact their...

Continue Reading
GMT Pay Revolutionizes Everyday Spending with Web3 Earnings

Updated Category News Views 151

GMT Pay: A New Era in Payment Solutions Welcome to the exciting world of GMT Pay, the groundbreaking payment solution that allows users to turn their Web3 earnings into everyday purchases. This innovative platform is spearheaded by FSL, the development studio behind the renowned Web3 lifestyle app, STEPN. With GMT Pay, users can easily access their earnings from various...

Continue Reading
Trucept, Inc. Unveils 2022 Financial Results and Future Prospects

Updated Category News Views 40

Trucept, Inc. Announces Major Financial Developments Trucept Inc. DBA Afinida is excited to share its audited financial results for the year 2022. With a keen focus on delivering transparency, the company underscores its commitment to its shareholders and clients alike. CEO Norman Tipton expresses optimism about the upcoming 2023 financial report, which is expected to be...

Continue Reading
Bitcoin's Critical Support Level for Future Growth Explained

Updated Category News Views 174

Understanding Bitcoin's Correction Phase Bitcoin's (CRYPTO: BTC) ongoing correction phase has garnered much attention among traders and investors alike. Key Insights From Technical Analysis Technical analyst Kevin has pointed out that Bitcoin's correction patterns notably exhibit similarities across different market cycles. Historically, even amidst various macroeconomic...

Continue Reading